Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06963515

Cutting-edge IMAGING Technologies to Improve the SAFEty and the Sustainability of LUNG Cancer Screening and the Accuracy of Non-invasive Lung Nodules Characterization

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
IRCCS San Raffaele · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers

Summary

Low-dose computed tomography (LDCT) is used in individuals at high risk of developing lung cancer (smokers over 50 years of age), as it allows for the identification of pulmonary nodules, which, in a small percentage of cases, may represent early-stage lung cancer. However, according to LUNG-RADS guidelines, individuals undergoing screening must repeat multiple LDCT scans, as the comparison between successive LDCT scans enables the assessment of existing nodules' progression and the identification of newly developed pulmonary nodules. This results in cumulative exposure to ionizing radiation, increasing the risk of radiation-induced cancers. This study addresses, through the implementation of new imaging techniques utilizing the latest and most advanced technological innovation (high-field 3T Magnetic Resonance Imaging (MRI) with artificial intelligence), the critical challenge of reducing radiation exposure in current LDCT-based screening programs, proposing the use of MRI as an alternative screening method to LDCT.

Conditions

Interventions

TypeNameDescription
PROCEDUREMagnetic Resonance Imaging3T Magnetic Resonance Imaging

Timeline

Start date
2025-06-20
Primary completion
2027-06-20
Completion
2028-06-20
First posted
2025-05-09
Last updated
2025-05-09

Source: ClinicalTrials.gov record NCT06963515. Inclusion in this directory is not an endorsement.